Sedation in Endoscopic Retrograde Cholangiopancreatography (ERCP) With or Without Opioids
CompletedNot applicableNCT01304342
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Addition of fentanyl or remifentanil to the propofol produced sedation for scheduled ERCP will decrease the propofol requirements for predetermined sedation levels (as shown by Bispectral Index Monitor (BIS) monitor), will be associated with faster recovery monitored by Ramsay's and Observer's Assessment of Alertness/Sedation (OAAS) scores and BIS, less postoperative pain (assessed by Visual Analogue Scale=VAS) and less early cognitive impairment after sedation (as assessed by the MiniMental test).
Study details
- Official title
- The Effect of Intranasal Fentanyl Versus Remifentanil Infusion on Propofol Requirements During Elective Therapeutic ERCP, as Well on the Recovery, Pain, and Early Cognitive Function: A Randomized Control Trial
- Conditions
- Interventions
- Sponsor
- University of Athens
- Start date
- 2011-02
- Primary completion
- 2013-01
- Sex
- All
- Age range
- from 50 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Greece
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients both sexes * ASA I-III * aged between 45 and 75 years old * scheduled for interventional ERCP Exclusion Criteria: * patients receiving opioids or other analgesics, sedatives, hypnotics * allergic to drugs used in the study protocol * alcoholism * refuse to sign the informed consent and chronic pain
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01304342